LDS/Medical Tests/Treponema pallidum Nucleic Acid, Molecular

Treponema pallidum Nucleic Acid, Molecular

Syphilis is a sexually transmitted infection (STI) caused by the spirochete bacteria Treponema pallidum. Syphilis can be divided into three infectious stages; primary, secondary, early latent, and two non-infectious disease stages: late latent and tertiary.

During infection, a broad immune response is produced which consists of specific anti-treponemal and non-specific (cardiolipin) antibodies. During primary syphilis, treponemal IgM may be detected within approximately two weeks post-infection and IgG at about four weeks post-infection. Antibodies can usually be detected by the time clinical symptoms appear.

Currently, two types of assays are used for diagnosis of syphilis: non-treponemal antibody testing and treponemal antibody testing. The non-treponemal tests for syphilis in use today are flocculation tests using the basic antigen formula of the Venereal Disease Research Laboratory (VDRL) test, which contains cardiolipin, cholesterol, and lecithin. The rapid plasma reagin (RPR) test uses a stabilized suspension to which charcoal particles have been added. These tests are not very sensitive. The treponemal antibody tests are antibody-based tests that detect antibody to T. pallidum.

Currently two treponemal tests are considered the standard for syphilis testing. The FTA-ABS test is an indirect immunofluorescent antibody test. The FTA-ABS test is sensitive and must be well controlled. Hemagglutination (MHA-TP) tests using treponemal antigen for T. pallidum have gained acceptance as a confirmatory procedure following a reactive non-treponemal assay or as a screening procedure. These assay methods all require visual interpretation and are limited to subjective interpretation by the operator. The use of the more specific enzyme immunoassay has received widespread acceptance due to better sensitivity and specificity. This syphilis immunoassay uses recombinant antigen that is specific for detection of IgM antibody to Treponema pallidum.

  • As an aid in the diagnosis of active T. pallidum infection
  • Differential diagnosis of active infection/disease

Positive result confirm infection with Treponema pallidum. 

Not Detected (Negative)

Real-time polymerase chain reaction (PCR), transcription mediated amplification (TMA), other molecular methods.

Serum (SST) or plasma (EDTA). Also, culture specimens can be used for detection. 

Stability

  • Ambient: 3-5 days
  • Refrigerated: 5-7 days
  • Frozen: 30 days

RPR, Treponemal Antibody by IFA, Anti-phospholipid antibody in patients with positive VDRL.

3-5 days. 

Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Sex Transm Dis. 1998;25:569. [PMID: 9858355]
  • Int J STD AIDS. 1995 Jul-Aug;6(4):241-8. [PMID: 7548285]
  • J Emerg Med. 2000;18:361. [PMID: 10729677]
  • Dermatol Clin. 2006;24:497. [PMID: 17010778]
  • Stevens CD. Clinical Immunology & Serology A Laboratory Perspective 3rd edition. Philadelphia: F.A. Davis Company (2010).